
### [NCIT:C7515](http://purl.obolibrary.org/obo/NCIT_C7515)
**Label:** Renal Pelvis and Ureter Carcinoma

**Subclasses:** [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C4830](http://purl.obolibrary.org/obo/NCIT_C4830) (Ureter Urothelial Carcinoma), [NCIT:C7520](http://purl.obolibrary.org/obo/NCIT_C7520) (Stage II Renal Pelvis and Ureter Carcinoma), [NCIT:C6156](http://purl.obolibrary.org/obo/NCIT_C6156) (Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation), [NCIT:C7522](http://purl.obolibrary.org/obo/NCIT_C7522) (Stage IV Renal Pelvis and Ureter Carcinoma), [NCIT:C7521](http://purl.obolibrary.org/obo/NCIT_C7521) (Stage III Renal Pelvis and Ureter Carcinoma), [NCIT:C6157](http://purl.obolibrary.org/obo/NCIT_C6157) (Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation), [NCIT:C8254](http://purl.obolibrary.org/obo/NCIT_C8254) (Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C6152](http://purl.obolibrary.org/obo/NCIT_C6152) (Stage III Ureter Cancer), [NCIT:C6151](http://purl.obolibrary.org/obo/NCIT_C6151) (Stage II Ureter Cancer), [NCIT:C6153](http://purl.obolibrary.org/obo/NCIT_C6153) (Stage IV Ureter Cancer), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C8064](http://purl.obolibrary.org/obo/NCIT_C8064) (Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C39879](http://purl.obolibrary.org/obo/NCIT_C39879) (Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7519](http://purl.obolibrary.org/obo/NCIT_C7519) (Stage I Renal Pelvis and Ureter Carcinoma), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C7716](http://purl.obolibrary.org/obo/NCIT_C7716) (Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C6148](http://purl.obolibrary.org/obo/NCIT_C6148) (Renal Pelvis Papillary Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C7355](http://purl.obolibrary.org/obo/NCIT_C7355) (Renal Pelvis Urothelial Carcinoma), [NCIT:C6145](http://purl.obolibrary.org/obo/NCIT_C6145) (Stage II Renal Pelvis Carcinoma), [NCIT:C6144](http://purl.obolibrary.org/obo/NCIT_C6144) (Stage I Renal Pelvis Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C8168](http://purl.obolibrary.org/obo/NCIT_C8168) (Regional Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C6147](http://purl.obolibrary.org/obo/NCIT_C6147) (Stage IV Renal Pelvis Carcinoma), [NCIT:C6146](http://purl.obolibrary.org/obo/NCIT_C6146) (Stage III Renal Pelvis Carcinoma), [NCIT:C8167](http://purl.obolibrary.org/obo/NCIT_C8167) (Localized Urothelial Carcinoma of the Renal Pelvis and Ureter), [NCIT:C6186](http://purl.obolibrary.org/obo/NCIT_C6186) (Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant), [NCIT:C6150](http://purl.obolibrary.org/obo/NCIT_C6150) (Stage I Ureter Cancer), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C54557](http://purl.obolibrary.org/obo/NCIT_C54557) (Renal Pelvis Urothelial Cell) 54.17%
- [NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q) 54.17%
- [NCIT:C36636](http://purl.obolibrary.org/obo/NCIT_C36636) (Loss of Chromosome 9p) 54.17%
- [NCIT:C36499](http://purl.obolibrary.org/obo/NCIT_C36499) (Loss of Chromosome 17p) 54.17%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 54.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 54.17%
- [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 54.17%
- Thing 52.82%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CL:1001428](http://purl.obolibrary.org/obo/CL_1001428) (bladder urothelial cell))) 39.52%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) 33.03%
- [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 33.03%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) and [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 33.03%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 33.03%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 33.03%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 33.03%


